142 related articles for article (PubMed ID: 9734623)
1. Prevalence of histological beta2-microglobulin amyloidosis in CAPD patients compared with hemodialysis patients.
Jadoul M; Garbar C; Vanholder R; Sennesael J; Michel C; Robert A; Noël H; van Ypersele de Strihou C
Kidney Int; 1998 Sep; 54(3):956-9. PubMed ID: 9734623
[TBL] [Abstract][Full Text] [Related]
2. Beta2-microglobulin amyloidosis in hemodialysis and peritoneal dialysis patients.
Dervisoglu E; Anik Y; Erdogan S; Akansel G; Yilmaz A
Ther Apher Dial; 2008 Aug; 12(4):306-10. PubMed ID: 18789118
[TBL] [Abstract][Full Text] [Related]
3. Histological characteristics of sternoclavicular beta 2-microglobulin amyloidosis and clues for its histogenesis.
Garbar C; Jadoul M; Noël H; van Ypersele de Strihou C
Kidney Int; 1999 May; 55(5):1983-90. PubMed ID: 10231463
[TBL] [Abstract][Full Text] [Related]
4. Clinical, radiological and serum amyloid P component scintigraphic features of beta2-microglobulin amyloidosis associated with continuous ambulatory peritoneal dialysis.
Tan SY; Baillod R; Brown E; Farrington K; Soper C; Percy M; Clutterbuck E; Madhoo S; Pepys MB; Hawkins PN
Nephrol Dial Transplant; 1999 Jun; 14(6):1467-71. PubMed ID: 10383009
[TBL] [Abstract][Full Text] [Related]
5. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
McCarthy JT; Williams AW; Johnson WJ
J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
[TBL] [Abstract][Full Text] [Related]
6. Scintigraphic methods to detect beta2-microglobulin associated amyloidosis (Abeta2-microglobulin amyloidosis).
Floege J; Schäffer J; Koch KM
Nephrol Dial Transplant; 2001; 16 Suppl 4():12-6. PubMed ID: 11402091
[TBL] [Abstract][Full Text] [Related]
7. Continuous ambulatory peritoneal dialysis vs haemodialysis: a lesser risk of amyloidosis?
Tielemans C; Dratwa M; Bergmann P; Goldman M; Flamion B; Collart F; Wens R
Nephrol Dial Transplant; 1988; 3(3):291-4. PubMed ID: 3140103
[TBL] [Abstract][Full Text] [Related]
8. Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study.
Jadoul M; Garbar C; Noël H; Sennesael J; Vanholder R; Bernaert P; Rorive G; Hanique G; van Ypersele de Strihou C
Kidney Int; 1997 Jun; 51(6):1928-32. PubMed ID: 9186884
[TBL] [Abstract][Full Text] [Related]
9. The pathology and changing epidemiology of dialysis-related cardiac beta-2 microglobulin amyloidosis.
Morris AD; Smith RN; Stone JR
Cardiovasc Pathol; 2019; 42():30-35. PubMed ID: 31226597
[TBL] [Abstract][Full Text] [Related]
10. [Serum beta 2-microglobulin concentration and its removal in patients treated with continuous ambulatory peritoneal dialysis].
Kubo H; Kawaguchi Y; Aizawa S; Morita T; Nakayama M; Wakabayashi Y; Watanabe S; Ogawa A; Sakai O
Nihon Jinzo Gakkai Shi; 1990 Apr; 32(4):419-26. PubMed ID: 2198365
[TBL] [Abstract][Full Text] [Related]
11. Recombinant versus natural human 111In-beta2-microglobulin for scintigraphic detection of Abeta2m amyloid in dialysis patients.
Schäffer J; Burchert W; Floege J; Gielow P; Kionka C; Linke RP; Weiss EH; Shaldon S; Koch KM
Kidney Int; 2000 Aug; 58(2):873-80. PubMed ID: 10916113
[TBL] [Abstract][Full Text] [Related]
12. Beta 2-microglobulin amyloidosis in a patient treated exclusively by continuous ambulatory peritoneal dialysis.
Jadoul M; Noel H; van Ypersele de Strihou C
Am J Kidney Dis; 1990 Jan; 15(1):86-8. PubMed ID: 2403753
[TBL] [Abstract][Full Text] [Related]
13. Morbidity and mortality of CAPD and hemodialysis.
Maiorca R; Cancarini GC; Brunori G; Camerini C; Manili L
Kidney Int Suppl; 1993 Feb; 40():S4-15. PubMed ID: 8445838
[TBL] [Abstract][Full Text] [Related]
14. Development of gastrointestinal beta2-microglobulin amyloidosis correlates with time on dialysis.
Jimenez RE; Price DA; Pinkus GS; Owen WF; Lazarus JM; Kay J; Turner JR
Am J Surg Pathol; 1998 Jun; 22(6):729-35. PubMed ID: 9630180
[TBL] [Abstract][Full Text] [Related]
15. Comparison of severity of acquired renal cysts between CAPD and hemodialysis.
Ishikawa I; Shikura N; Nagahara M; Shinoda A; Saito Y
Adv Perit Dial; 1991; 7():91-5. PubMed ID: 1680465
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G
J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976
[TBL] [Abstract][Full Text] [Related]
17. Beta-2 microglobulin amyloidosis in a patient on long-term continuous ambulatory peritoneal dialysis (CAPD).
Colombi A; Wegmann W
Perit Dial Int; 1989; 9(4):321-4. PubMed ID: 2535112
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis G virus infection in hemodialysis and continuous ambulatory peritoneal dialysis patients.
Noh H; Kang SW; Choi SH; Shin SK; Seo BJ; Lee IH; Choi KH; Han DS; Kim HS; Lee HY
Yonsei Med J; 1998 Apr; 39(2):116-21. PubMed ID: 9587251
[TBL] [Abstract][Full Text] [Related]
19. Hemodialysis-related amyloidosis: Is it still relevant?
Kaneko S; Yamagata K
Semin Dial; 2018 Nov; 31(6):612-618. PubMed ID: 29896815
[TBL] [Abstract][Full Text] [Related]
20. Beta-2 microglobulin in patients on peritoneal dialysis and hemodialysis.
Scalamogna A; Imbasciati E; De Vecchi A; Castelnovo C; Pagliari B; De Cristofaro V; Ponticelli C
Perit Dial Int; 1989; 9(1):37-40. PubMed ID: 2488178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
